Research Assessment Seeks Evidence to Guide Treatment of MPN With COVID-19
Investigators assessed studies for evidence to guide the management of MPN in patients with COVID-19.
All articles by Jennifer Larson
Utilization Patterns Explain Nonadherence to Treatment for Multiple Myeloma, CML, Some Metastatic Cancers
A retrospective study of Medicare data showed a potential factor in nonadherence to oral cancer treatment regimens.
Pretreatment Found to Reduce Stages of Mohs Surgery for Basal Cell Carcinoma
A retrospective study evaluated the effect of 5% imiquimod prior to Mohs surgery in patients with basal cell carcinoma.
New-Generation BCR-ABL TKIs Linked to Increased Risk of Hepatotoxicity in Patients With Chronic Myeloid Leukemia
Researchers sought to determine the risk of hepatotoxicity for patients with CML treated with 4 newer TKIs compared with imitanib.
Study Finds Association Between Hypertension and Ibrutinib Treatment
Researchers defined the association between blood pressure and ibrutinib compared with chemoimmunotherapy in patients with B cell malignancies.
Fertility Preservation Delays Breast Cancer Treatment But Doesn’t Affect Survival
An analysis of data sought to determine the effect of delays related to fertility preservation on the initiation of treatment and overall survival.
Seroconversion After Full COVID-19 Vaccination Lower With Hematologic Malignancies, Lowest With Multiple Myeloma
A single-center study found anti-COVID-19 protection lowest in patients with MM at 2 weeks after their second BNT162b2 mRNA shot than did patients with myeloproliferative malignancies, and was highest in older patients without cancer.
Patients With MPN and Their Caregivers Could Benefit from Greater Support, Interventions
During a residential rehabilitation program, researchers interviewed participants to determine their supportive care and rehabilitation needs.
HDMTX Promising for Patients With Primary CNS Lymphoma Ineligible for Clinical Trials
Researchers compared outcomes in patients with PCNSL who did not meet clinical trial criteria with those of patients from a major multicenter clinical trial of PCNSL.
How Knowledge of Treatment Assignment Affects Patient Reported Data in Multiple Myeloma Clinical Trials
Researchers sought to determine if knowing treatment assignment would lead to patient bias among participants in multiple myeloma clinical trials.
- Loading...
Loading...
Next post in Multiple Myeloma
Loading... 
Loading...